Eribulin Versus Dacarbazine in Patients With Leiomyosarcoma: Subgroup Analysis From a Phase 3, Open-Label, Randomised Study

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0462-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy and Safety of Trabectedin or Dacarbazine for the Treatment of Patients With Uterine Leiomyosarcoma After Prior Chemotherapy: A Subgroup Analysis of the Randomized Phase 3 SAR-3007 Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine

British Journal of Cancer
Cancer ResearchOncology
2019English

Ibrutinib Versus Temsirolimus: 3-Year Follow-Up of Patients With Previously Treated Mantle Cell Lymphoma From the Phase 3, International, Randomized, Open-Label RAY Study

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Response-Adapted Intensification With Cyclophosphamide, Bortezomib, and Dexamethasone Versus No Intensification in Patients With Newly Diagnosed Multiple Myeloma (Myeloma XI): A Multicentre, Open-Label, Randomised, Phase 3 Trial

The Lancet Haematology
Hematology
2019English

Pomalidomide Plus Low-Dose Dexamethasone Versus High-Dose Dexamethasone Alone for Patients With Relapsed and Refractory Multiple Myeloma (MM-003): A Randomised, Open-Label, Phase 3 Trial

The Lancet Oncology
Oncology
2013English

A Randomised, Open-Label, Crossover Study of the Dopamine Agonist, Pramipexole, in Patients With Sleep Bruxism

Journal of Sleep Research
MedicineBehavioral NeuroscienceCognitive Neuroscience
2016English

Infliximab for Pediatric Patients With Ulcerative Colitis: A Phase 3, Open-Label, Uncontrolled, Multicenter Trial in Japan

BMC Pediatrics
Child HealthPediatricsPerinatology
2019English

Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine as a Preparative Regimen for Allogeneic Haemopoietic Stem-Cell Transplantation in Patients With Acute Myeloid Leukaemia: An Open-Label, Multicentre, Randomised, Phase 3 Trial

The Lancet Oncology
Oncology
2015English

A Multi-National, Randomised, Open-Label, Parallel, Phase III Non-Inferiority Study Comparing NK105 and Paclitaxel in Metastatic or Recurrent Breast Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy